563 Episodes

  1. Developing Immunotherapies that Target the Drivers of Cancer

    Published: 6/14/2023
  2. Using Phase 0 Trials to Bring Precision Medicine to Treating Brain Tumors

    Published: 6/7/2023
  3. Restoring Feeling and Function to Damaged Nerves

    Published: 5/31/2023
  4. Enlisting Vaccines in the Fight Against Chronic Diseases

    Published: 5/24/2023
  5. Extending the Reach of Protein Degradation Therapies

    Published: 5/17/2023
  6. Growing the Bioeconomy

    Published: 5/10/2023
  7. Developing Targeted Therapies to Address Resistance in Cancer

    Published: 5/3/2023
  8. It Takes a Village

    Published: 4/26/2023
  9. Bringing Stick-to-itiveness to Regenerative Medicine

    Published: 4/19/2023
  10. A Biopharma Downturn or Return to Trend

    Published: 4/12/2023
  11. Treating Aging-Related Disease by Targeting Molecular Drivers of Aging

    Published: 4/5/2023
  12. Engineering Better Cell Therapies for Cancers

    Published: 3/29/2023
  13. Targeting a Regulator of Inflammation to Treat Alzheimer’s Disease

    Published: 3/22/2023
  14. Enabling Regenerative Therapies without Immunosuppression

    Published: 3/15/2023
  15. Making Vaccine and Biotherapeutic Production Fast and Affordable

    Published: 3/8/2023
  16. Forcing Cancers to Reveal Themselves

    Published: 3/1/2023
  17. Making Clinical Trials Diverse and Accessible

    Published: 2/23/2023
  18. Mining Bugs for Drugs

    Published: 2/16/2023
  19. A Company That Bets Its Therapies Will Click with Patients

    Published: 2/9/2023
  20. A Company Where It takes Guts and Brains to Develop Drugs

    Published: 2/2/2023

6 / 29

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.